Colorectal cancer, which is the third most frequent cancer and the cancer with the second highest mortality rate, frequently develops on a pre-existing adenomatous polyps whose slow growth and malignant degeneration can be identified and controlled by effective screening. Although most lesions can be detected and resected during optical colonoscopy (OC), the cost, risk and poor acceptance of this technique by the general population means that it is reserved for high-risk or very high-risk individuals. The fecal occult blood test (FOBT) (such as the Hemoccult ® ) is proposed for intermediate-risk individuals between 50 and 75 years old. However, despite the improvements that have been made in this method, sensitivity is low, and although it is simple, it is too rarely used. CT colonography (virtual colonoscopy) is proposed in case of failure, additional risk factors or refusal of optical colonoscopy in high-risk patients or in the presence of a positive FOBT. It should also be proposed as an alternative to the FOBT test to patients who accept the constraints of this technique.
In 2012, colorectal cancer (CRC) was the third most frequent cancer, with 42,152 new cases in France, after prostate and breast cancer. It was the cause of 17,722 deaths, making it the cancer with the 2 nd highest mortality after lung cancer. Although the global incidence has been stable for many years, mortality has decreased from nearly 20% in 1980 to less than 14% in 2010 in men and slightly less in women. The decrease has slowed since then. This decrease is due to more effective treatment, including of liver metastases as long as they are isolated and that a portion of the liver parenchyma is disease free. The development of an organized CRC screening program based on the fecal occult blood test (FOBT) has resulted in somewhat earlier detection of these cancers or treatment of adenomatous polyps, which are precancerous lesions. However this mass-screening program has two major limitations:
• poor participation, approximately 33% of the French population; • low sensitivity.
Indeed the sensitivity of this approach is approximately 50% for the diagnosis of cancer and approximately 10% for the diagnosis of an adenoma larger than 10 mm. Of course, the risk of mortality from CRC is reduced by 30% in participants in the screening campaign, although the test only provides earlier diagnosis of approximately half of the cancers in this population, while it does not, like colonoscopy in high-risk patients, effectively diagnose precancerous lesions.
CT colonography is an effective, very low risk technique to explore the colon, which could play a role in cancer screening: to determine its role, we must first understand the basis of CRC screening.
The basis of screening

Adenoma-cancer sequence
More than 60% of CRC develop from adenomatous polyps, initially benign lesions with a risk of malignant transformation. The risk of malignant degeneration increases with the size of the polyp (above 1 cm, because below, the risk is less than 0.3%), the presence of a villous component and the degree of dysplasia. This ''adenoma-cancer sequence'' is very slow and takes a mean 10-20 years except in the right colon where serrated polyps, whose carcinogenesis is more rapid, are located. Only an estimated 100/1000 (10%) adenomas followed for 10 years will grow to 10 mm and 25 (2.5%) will become malignant. It is therefore clear that colonoscopy and removal of large polyps can significantly reduce the development of colorectal cancer, except in the right colon. However, it is not possible to propose this uncomfortable, expensive test, associated with a certain risk (0.3% for perforation as well as the risks associated with anesthesia) to the general population. It is only proposed to high risk or very high risk patients.
Level of risk
The risk can be classified into three levels:
• average risk corresponds to the general population over the age of 50. The mean age of patients at diagnosis is 70 years old. The highest risk is at approximately 80 years old. In France, diagnostic screening in this group is based on the FOBT every two years; • high risk is associated, in particular, with a history of CRC or a polyp of more than one cm. A personal history of CRC is not limited by age if it involves the patient or two first-degree relatives. However, lesions detected before the age of 65 are taken into account if only one member of the family is concerned. In addition, patients with extensive, chronic inflammatory disease of the intestine for more than 10 years at diagnosis are also considered high-risk. In this high-risk group, screening is based on regular colonoscopy after the age of 45, or earlier, five years before the index case. Colonoscopy is repeated every five years. This delay is shortened to three years if an adenoma of more than 1 cm or with a villous growth pattern is detected. It is reduced to 5 years again after a normal test; • very high risk includes patients with genetic diseases such as familial adenomatous polyposis with several hundred polyps in the colon or the Lynch syndrome (or hereditary non polyposis colorectal cancer [HNPCC]) with early onset cancer, in particular colorectal cancer, but which may involve other organs especially the endometrium. Regular colonoscopies should be performed after adolescence. Prevention may even include preventive coloprotectomy during adolescence.
Besides this very specific context, it is clear that effective prevention must include early diagnosis of lesions larger than a centimeter as of the age of 50 and especially between 65 and 75 or older depending on the patient's physiological condition.
Screening methods
An effective screening method should be easy to perform, sensitive, inexpensive and accepted by the patient. There are numerous screening methods [1] :
• the detection of FOBT is performed by the patient by six fecal smears. This test is inexpensive and accepted by patients (approximately 30%), but its efficacy in detecting advanced adenomas is poor, approximately 10%; its advantage is that it provides early diagnosis of half the cancers in this population. The test must be performed every two years to be effective. Marketing of an immunological test (OC-Sensor ® or Magstream ® ), which only requires a fecal sample, is easier, simpler and slightly more specific. This should improve results, but mainly in the detection of cancers rather then pre-cancerous lesions; • search for the presence of tumoral DNA in stools or blood is also possible. This test is more sensitive but more expensive and is only reimbursed by a few mutual insurance policies; • sigmoidoscopy is offered in numerous countries. It is based on the fact that most (60%) lesions are located in the sigmoid colon and that it can be performed without general anesthesia. However, the colon must be cleansed by an enema. This test is more difficult than a stool sample for the patient, and the entire colon is not investigated; • colonoscopy is considered to be the best method, because polyps can be diagnosed and resected. Nevertheless it has several limitations. Its results are not perfect, in particular in the right colon. It is incomplete in 5% of the cases, but even if it is complete, colonoscopy does not identify 15-25% of adenomas less than 1 cm, 0-6% of adenomas larger than 1 cm and 0.5-6% of CRC. It is associated with a certain risk in addition to the risk of anesthesia, which is very low except in frail patients, and especially perforation (0.1% for colonoscopy without polypectomy). It generally requires hospitalization and sick leave the day of the test and often the day before for the preparation. It is therefore expensive; • finally CT colonograpy is an alternative to colonoscopy but only for detection. The use of this technique is still too limited in France.
CT colonography
This technique was introduced 20 years ago and it has gradually improved with optimization of bowel preparation, the quality of insufflation, sensitivity of CT scan sequences and improvements in visualization software, which also includes functions of automatic detection.
Colon preparation
It is generally based on a fiber-free diet, laxatives, increasingly replaced by a small quantity of polyethylene glycol (PEG). Fecal residue is tagged by ingestion of an iodated contrast medium the day before the examination. This preparation could be simplified to ingestion of the oral contrast medium alone to improve acceptance of this test for a mass-screening program. If colonoscopy is unsuccessful, a complementary CT colonography performed before the end of the anesthesia in the prepared colon can be useful. Liquids should be tagged by having the patient drink 25 cL of water containing 10% iodated contrast medium one hour before the test.
Colonic insufflation
It should be performed by insufflation of CO 2 using a rectal catheter and bulb. Insufflation should be gradual. Pressure is controlled by the device to prevent excess pressure, which could cause perforation. An average of three liters of air is insufflated, but this depends upon the size of the colon and is increased in case of leaks, in particular ileo-caecal valve incontinence with reflux into the small intestine. When the colon is fully distended, the patient has gas pains that may become intensely painful. Distension time may be limited by preparing the acquisition before full distension and by increasing pressure at the last minute. CO 2 reduces the patient's discomfort in the immediate postexamination period because it is partially absorbed by the colonic mucosa.
Image acquisition
After at least one liter of insufflation, an adjusted scoutview is performed to position the slices so that the entire colon will be covered, leaving some leeway above to avoid cutting off a flexure. Infra-millimeter slices are not necessary because they often entail more radiation; the number of artefacts may be increased, as well as producing more images, limiting the fluidity of the 3D analysis. Radiation should be limited, for example by using 100 kV with a tube current of 35-70 mAs depending on the weight of the patient or automated with a high level of noise (for example 75 mAs for a general electric device). In this case, a dose-length product (DLP) of less than 300 mGy.cm is obtained for the entire test. Images should be obtained with the patient in two positions, supine and prone or in both decubitus lateral positions if the patient is overweight, to move remaining fecal residue or pendunculated polyps.
Interpretation and reading of results
2D interpretation
A primary 2D interpretation of images is performed with very large lung-size window widths to analyze the lumen of the colon. Any segments that are incomplete should be identified in this primary series of images, so that they can be obtained in the second series. If necessary, a third series should be obtained. Any lesions larger than a centimeter should be identified in this primary reading. The images should also be read in a narrower window width abdominal, for example, to identify extracolonic lesions (bladder, kidneys, aorta. . .)
3D interpretation
3D interpretation can be used to identify infracentimetric lesions that cannot be seen on 2D images. The first step is to define the central line. 3D interpretation can be performed using endoluminal navigation or ''fly-through'' views or by virtual dissection that ''flattens'' the colon. This latter method avoids antegrade and retrograde fly-throughs, by reversing the sense of the virtual camera. It requires specific training because it results in distortions, in particular of the sharp curves of the colon, as well as changes in the perception of reliefs. Computed aided detection (CAD) can facilitate lesion detection, especially if the colon is clean and relaxed. It reduces reading time and improves the results of less experienced radiologists [2] .
Density measurement
When a polyp-type lesion is identified on 3D, its density must first be determined. The density of tumor tissue is similar to that of the wall of the colon while a lipoma or an inverted diverticulum is fatty and fecal residue is dense if it has been correctly tagged by contrast medium taken by patient the day before. If the lesion seems to have a soft tissue density it must be identified again in the same spot in an additional image to exclude non-tagged mobile residue ( Fig. 1 ).
C-RADS Classification
The C-RADS [3] classification provides a standardized description of each lesion including:
• the segment of the colon as well as the side if the lesion is in a flexure; • the shape of the lesion: sessile or pendunculated, flat with or without a depressed surface, irregular, or stenotic; • the largest diameter of the head of the polyp (without taking into account a possible stalk. . .) while mentioning whether 2D or 3D visualization was used; • the type of density of the lesion (cf. supra).
This classification proposes an approach ( Table 1) that is not officially accepted in France, but which seems to be coherent with the level of risk of malignant degeneration in relation to the size of the lesion. ''Diminutive'' lesions of less than 6 mm can be left. On the other hand a followup colonoscopy is indicated in the presence of lesions that Figure 1 . Numerous polyps of the right colon in a patient who has already had several adenomas resected. CT colonography shows a sigmoid lesion (not shown) and small anomalies of the right colon, which illustrate the practical approach with this method: a: CT colonography view with flattening of the right colon from the series of images in the decubitus position. A grey band can be seen on top and on are larger than 10 mm or more than three lesions larger than 5 mm. Other than these cases, follow-up by CT colonography or colonoscopy can be proposed.
Extracolonic lesions
Extra-colonic lesions can also be identified with CT colonography. Certain lesions have no practical impact, others require follow-up or even therapeutic management. The impact of these lesions is also classified by the C-RADS. Although their diagnosis usually provides additional benefit to the patient, there is also a risk of detecting lesions that do not have any impact.
Performance
The greatest difficulty of this technique is that it is complicated to learn to obtain adequate distension and especially reading and interpretation. Indeed, specific training including reading at least 50 cases is necessary to reach a minimum level of expertise as well as to avoid the main pitfalls of this technique. A highly experienced radiologist can reach a level of detection that is similar to that of colonoscopy, or approximately 90% of 8 mm lesions or lesions that are larger than 4-5 mm ( Table 2 ) [4] [5] [6] [7] . The differences observed in the multicenter French study were because certain teams had just begun to use this technique while others had more experience [7] . The final results of the readers were correlated to those obtained in the 50 training cases. The most experienced readers at the beginning of the study still obtained better results, despite training that should theoretically have been sufficient for all. The efficacy of CAD can partially compensate for these differences.
The role of CT colonography
In 2012, the French National Health Authorities (Haute Autorité de santé [HAS]) associated with expert medical societies defined the indications for CT colonography [8] . CT colonography is not indicated for screening in very high-risk patients.
In high or intermediate risk patients with a positive FOBT it should be proposed:
• as a complementary test in case if incomplete colonoscopy (Fig. 2) ; • in case of co-morbidities that increase the risk of colonoscopy; • or in case of refusal of colonoscopy.
The indication for CT colonography should be validated by the patient's clinical physician and the radiologist who is the bottom, which corresponds to a repetition of part of the circumference. CAD shows several anomalies, colored in blue (A-D), which are seen in detail in other views; b: lesion A. 3D endoluminal view. It is located in the hepatic flexure between two folds, and was not seen spontaneously during colonoscopy. The gastroenterologist was aware of its presence and found it later; c: lesion A. 2D view, confirming the soft tissue density; d: lesion A. 3D view of an additional acquisition. It is found in the same place; e: lesion B 3D endoluminal view. It resembles a polyp; f: lesion B. 2D view, showing a dense anomaly, suggesting residue; g: flattened view of the same portion of the colon but from procubitus slices. Lesions A, C and D are seen aligned but the location of B corresponding to residue has changed and is now after (more to the left) lesion A; h: lesion C (polyp). 3D view; i: lesion C. 2D view. Soft tissue density; j: lesion D (polyp). 3D view. It is located in a fold; k: lesion D. 2D view. Soft tissue density, that is not easy to detect on 2D because it is lost in the fold. performing the examination to adapt the bowel preparation and the technical protocol to the clinical context and any existing co-morbidities. In France, CT colonography is not proposed for mass screening programs. From a medicoeconomic standpoint, CT colonography every 10 years should be less expensive and more effective than a Hemoccult ® test every two years [9, 10] . However, it is obviously impossible to offer a CT scan to the general population because there are not enough machines and the rate of acceptance would be low, which would cancel the usefulness of screening. Colon preparation that does not require taking a laxative but an oral contrast medium for several days might improve acceptance slightly, but overall this technique has too many constraints to be widely accepted [11] . On the other hand, it should be recognized and covered by National Health Insurance in patients who accept the constraints of this test, which is not the case today in France [12] .
Certain insurance policies in other countries such as the United States propose and even require screening for colon lesions by colonoscopy or increasingly frequently by CT colonography. In 2007, Kim compared the two strategies and analyzed two similar groups of more than 3000 patients [13] . One hundred twenty-one advanced adenomas or cancers were discovered with seven perforations in the group that underwent colonoscopy as the first line screening test. In the group that underwent CT colonography as the first line screening test, 246 colonoscopies were performed based on C-RADS criteria or 7.8% of patients, resulting in a diagnosis of 123 advanced adenomas or cancers, and no perforations. The influence of mass screening by CT colonography on mortality will not be known for many years. In any case as long as screening tests are not required by mutual insurance companies, this should still be recognized as an acceptable test in France.
On the other hand from a medicoeconomic standpoint, individual patients who have understood what is at stake and who want an effective test for precancerous lesions and not just cancer, should certainly be proposed CT colonography performed by an experience team rather than colonoscopy which is more expensive, has a higher risk, and with very little difference in results.
Conclusion
Colon preparation for CT colonography is slightly less difficult than that for colonoscopy, and this technique is associated with fewer risks, is less expensive and does not necessarily require sick leave.
CT colonoscopy is an effective screening test for advanced colon tumors (cancers and adenomas of more than 10 mm)
The results of reading and interpretation vary considerably depending on the readers, but an experienced reader can obtain results similar to those obtained by colonoscopy.
In high-risk patients with clinical symptoms or with a positive fecal occult blood test, colonoscopy is the first line test, and CT colonography is only proposed if colonoscopy is incomplete or cannot be performed because of patient refusal or additional risk factors.
In intermediate-risk patients, mass screening in France is based on the fecal occult blood test. This is moderately sensitive for cancers and has a very low sensitivity for adenomas.
In France, although CT colonography is not yet offered for mass screening in intermediate-risk populations, it is certainly preferable to colonoscopy for individual patients who would like more sensitive testing.
TAKE-HOME MESSAGES
• Colon cancer is one of the most frequent cancers (third most frequent). • Mortality from colon cancer is high (second highest).
• It often develops on a pre-existing, slow growing, lesion (adenoma). • Screening is based on:
• the detection and resection of lesions by colonoscopy in high risk patients, • or the detection of asymptomatic cancers by the FOBT or its more sensitive replacement, for intermediate-risk patients.
• CT colonography is the best alternative to screening by colonography. • It is performed after colon preparation, tagging of fecal matter by ingestion of iodated contrast medium the day before the test, and colon insufflation, preferably automated and with CO 2 . • Low dose radiation is sufficient.
• Two complementary views are obtained with the patient in two positions. • 3D visualization with CAD and sufficient training results in an efficacy close to that of colonoscopy. • CT colonography is indicated in case of failure, additional risk factors or refusal of colonoscopy. • It should also be offered to intermediate-risk patients who accept it as an alternative to the FOBT. • Epidemiological data to support this proposal do not exist at present.
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